J. Lipid Res.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1194/jlr.M300090-JLR200 on April 1, 2003

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
M300090-JLR200v1
44/6/1256    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, N.
Right arrow Articles by Matsuzawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, N.
Right arrow Articles by Matsuzawa, Y.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Lipid Research, Vol. 44, 1256-1262, June 2003
Copyright © 2003 by Lipid Research, Inc.

Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA1

Naohiko Sakai2,3,*, Yoshiaki Uchida2,{dagger}, Koji Ohashi*, Toshiyuki Hibuse*, Yasuhiko Saika*, Yoshiaki Tomari*, Shinji Kihara*, Hisatoyo Hiraoka*, Tadashi Nakamura*, Satoru Ito4,{dagger}, Shizuya Yamashita* and Yuji Matsuzawa*

* Department of Internal Medicine and Molecular Science, Osaka University Graduate School of Medicine, B5, 2-2 Yamadaoka, Suita, Osaka 565-0871, Japan
{dagger} Diagnostic Research Laboratories, Fujirebio, Inc., 51 Komiya-cho, Hachioji, Tokyo 192-0031, Japan

3 To whom correspondence should be addressed. e-mail: naosakai{at}imed2.med.osaka-u.ac.jp

The present study was designed to evaluate the metabolism of chylomicron and chylomicron remnants by measuring serum apolipoprotein B-48 (apoB-48) levels in 335 normolipidemic and 253 hyperlipidemic subjects using a novel ELISA system. The distribution of fasting serum apoB-48 levels in normolipidemic subjects varied widely, ranging from <1 to >24 µg/ml (mean, 5.2 ± 3.8 µg/ml; median, 3.9 µg/ml). Serum apoB-48 levels correlated with serum triglyceride (TG) concentrations (r = 0.45, P < 0.001), but not with total cholesterol levels. Serum apoB-48 levels were 7 to 18 times higher in patients with Type I, Type V, and Type III hyperlipidemia, and only slightly higher in patients with Type IIa, Type IIb, and Type IV hyperlipidemia, compared with normolipidemic subjects. The calculated apoB-48/TG ratio was elevated only in patients with dysbetalipoproteinemia (apoE2/2 phenotype). In normolipidemic subjects, oral fat loading resulted in about 2-fold increase in serum apoB-48 levels, with a peak level recorded at 3–4 h postloading, and then returned to the baseline level within 6 h. On the other hand, in patients with dysbetalipoproteinemia, serum apoB-48 levels did not change considerably.

Our results indicate that serum apoB-48 is a very useful parameter for evaluating lipoprotein metabolism in exogenous pathways.

Abbreviations: CHD, coronary heart disease; CV, coefficient of variation; LPL, lipoprotein lipase; RLP, remnant-like particle; RP, retinyl palmitate; TC, total cholesterol; TG, triglyceride; TRL, TG-rich lipoprotein

Supplementary key words apolipoprotein B-48 • atherosclerosis chylomicron dysbetalipoproteinemia • enzyme-linked immunosorbent assay • monoclonal antibody • postprandial hyperlipidemia • remnant


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Clin. Chem.Home page
D. C. Chan, G. F. Watts, T. W.K. Ng, Y. Uchida, N. Sakai, S. Yamashita, and P. H. R. Barrett
Adiponectin and other Adipocytokines as Predictors of Markers of Triglyceride-Rich Lipoprotein Metabolism
Clin. Chem., March 1, 2005; 51(3): 578 - 585.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B.-H. Chung, B. S. Cho, P. Liang, S. Doran, L. Osterlund, R. A Oster, B. Darnell, and F. Franklin
Contribution of postprandial lipemia to the dietary fat-mediated changes in endogenous lipoprotein-cholesterol concentrations in humans
Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1145 - 1158.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 2003 by the American Society for Biochemistry and Molecular Biology.